BETH EARLES: Open Payments
NPI 1225680127 · SALEM, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,708 in 108 payments from 20 companies in 2025. Trend: 2023 $721 · 2024 $1,289 · 2025 $1,708
Food & beverage: $1,708
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 32 | $368 |
| ABBVIE INC. | 16 | $278 |
| Lundbeck LLC | 13 | $259 |
| Neurocrine BioSciences, Inc. | 15 | $185 |
| ACADIA Pharmaceuticals Inc | 4 | $79 |
| Genentech USA, Inc. | 4 | $77 |
| Eisai Inc. | 3 | $62 |
| Amneal Pharmaceuticals LLC | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
Products named: NURTEC ODT, INGREZZA, QULIPTA, VYEPTI, REXULTI, UBRELVY, NUPLAZID, Ocrevus Zunovo.
Industry payments across OH — which companies pay providers there.
